【レポートの概要（一部）】
1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Clinical Segmentation Outlook 2018
4.1 Point-of-Care Diagnostics
4.2 Immunochemistry
4.3 Clinical Chemistry
4.4 Molecular Diagnostics
4.5 Hematology
4.6 Microbiology
4.7 Hemostasis
4.8 Immunohematology
5. Geographical Segmentation (Current & Future Scenario – 2018)
5.1 America
5.1.1 United States
5.1.2 Canada
5.1.3 Brazil
5.1.4 Mexico
5.2 Europe
5.2.1 Germany
5.2.2 France
5.2.3 Italy
5.2.4 United Kingdom
5.2.5 Spain
5.3 Asia-Pacific
5.3.1 Japan
5.3.2 China
5.3.3 India
6. Industry Trends
6.1 Fast Emerging Niche: Devices to Capture Circulating Tumor Cells
6.2 On the Horizon: Non-Invasive Genetic Tests for Cancer
6.3 Non-Invasive Prenatal Diagnostics Market Witnesses Boom
6.4 Companion Diagnostics Partnerships Gear Up
6.5 Predictive Cancer Diagnostic Test Market Rockets Northwards
6.6 POCT: Expanding Avenues into Multiple Disease Diagnosis
7. Competitive Landscape
7.1 Market Share of Top Players
7.2 Key Players
7.2.1 Abbott Laboratories
7.2.2 Alere, Inc.
7.2.3 Becton Dickinson
7.2.4 Bayer HealthCare
7.2.5 Beckman Coulter
7.2.6 Biomerieux
7.2.7 Johnson and Johnson
7.2.8 Life Technologies Corporation
7.2.9 Medtronic, Inc.
7.2.10 Qiagen NV
7.2.11 Roche Holding Ltd
7.2.12 Sysmex Corporation
7.2.13 Siemens HealthCare
7.2.14 Thermo Fisher Scientific
List of Figures:
Figure 3-1: Global – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 4-1: Global – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 4-2: Global – Point-of-Care Testing Market by Region (%), 2013
Figure 4-3: Global – Point-of-Care Testing Market by Players (%), 2013
Figure 4-4: Global – Point-of-Care Testing Market (Billion US$), 2013-2018
Figure 4-5: Global – Immunochemistry Testing Market by Region (%), 2013
Figure 4-6: Global – Immunochemistry Testing Market by Players (%), 2013
Figure 4-7: Global – Immunochemistry Testing Market (Billion US$), 2013-2018
Figure 4-8: Global – Clinical Chemistry Testing Market by Region (%), 2013
Figure 4-9: Global – Clinical Chemistry Testing Market by Players (%), 2013
Figure 4-10: Global – Clinical Chemistry Testing Market (Billion US$), 2013-2018
Figure 4-11: Global – Molecular Diagnostics Market by Region (%), 2013
Figure 4-12: Global – Molecular Diagnostics Market by Players (%), 2013
Figure 4-13: Global – Molecular Diagnostics Market (Billion US$), 2013-2018
Figure 4-14: Global – Hematology Testing Market by Region (%), 2013
Figure 4-15: Global – Hematology Testing Market by Players (%), 2013
Figure 4-16: Global – Hematology Testing Market (Billion US$), 2013-2018
Figure 4-17: Global – Microbiology Testing Market by Region (%), 2013
Figure 4-18: Global – Microbiology Testing Market by Players (%), 2013
Figure 4-19: Global – Microbiology Testing Market (Billion US$), 2013-2018
Figure 4-20: Global – Hemostasis Testing Market by Region (%), 2013
Figure 4-21: Global – Hemostasis Testing Market by Players (%), 2013
Figure 4-22: Global – Hemostasis Testing Market (Billion US$), 2013-2018
Figure 4-23: Global – Immunohematology Testing Market by Region (%), 2013
Figure 4-24: Global – Immunohematology Testing Market (Billion US$), 2013-2018
Figure 5-1: Global – In Vitro Diagnostic Market by Region (%), 2013
Figure 5-2: Global – In Vitro Diagnostic Market by Region (%), 2018
Figure 5-3: US – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-4: US – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-5: US – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-6: Canada – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-7: Canada – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-8: Canada – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-9: Brazil – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-10: Brazil – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-11: Brazil – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-12: Mexico – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-13: Mexico – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-14: Mexico – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-15: Europe – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-16: Europe – In Vitro Diagnostic Market by Country (%), 2013
Figure 5-17: Europe – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-18: Europe – In Vitro Diagnostic Market by Country (%), 2018
Figure 5-19: Europe – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-20: Germany – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-21: Germany – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-22: Germany – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-23: France – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-24: France – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-25: France – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-26: Italy – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-27: Italy – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-28: Italy – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-29: UK – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-30: UK – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-31: UK – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-32: Spain – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-33: Spain – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-34: Spain – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-35: Japan – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-36: Japan – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-37: Japan – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-38: China – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-39: China – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-40: China – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-41: India – In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-42: India – In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-43: India – In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 7-1: Global – In Vitro Diagnostic Market by Players (%), 2013
Figure 7-2: Abbott Laboratories – Break up of Revenue by Business Segment (%), 2013
Figure 7-3: Abbott Laboratories – Diagnostic Division Revenue by Segment (%), 2013
Figure 7-4: Alere Inc. – Break up of Revenue by Business Segment (%), 2012
Figure 7-5: Alere Inc. – Diagnostic Division Revenue by Segment (%), 2012
Figure 7-6: Becton Dickinson – Break up of Revenue by Business Segment (%), 2013
Figure 7-7: Becton Dickinson – Diagnostic Division Revenue by Segment (%), 2013
Figure 7-8: Bayer HealthCare – Break up of Revenue by Business Segment (%), 2013
Figure 7-9: Bayer HealthCare – Consumer Health Revenue by Segment (%), 2013
Figure 7-10: Beckman Coulter – Break up of Revenue by Business Segment (%), 2010
Figure 7-11: Beckman Coulter – Diagnostic Division Revenue by Segment (%), 2010
Figure 7-12: Biomerieux – Break up of Revenue by Business Segment (%), 2013
Figure 7-13: Biomerieux – Diagnostic Division Revenue by Segment (%), 2013
Figure 7-14: Johnson & Johnson – Break up of Revenue by Business Segment (%), 2013
Figure 7-15: Life Technologies Corporation – Break up of Revenue by Business Segment (%), 2012
Figure 7-16: Medtronic Inc. – Break up of Revenue by Business Segment (%), 2013
Figure 7-17: Qiagen NV – Break up of Revenue by Business Segment (%), 2013
Figure 7-18: Roche Holdings Ltd – Break up of Revenue by Business Segment (%), 2013
Figure 7-19: Roche Holdings Ltd – Diagnostic Division Revenue by Segment (%), 2013
Figure 7-20: Sysmex Corp. – Break up of Revenue by Business Segment (%), 2013
Figure 7-21: Sysmex Corp. – Diagnostic Division Revenue by Segment (%), 2013
Figure 7-22: Siemens HealthCare – Diagnostic Division Revenue by Segment (%), 2013
Figure 7-23: Thermo Fisher Scientific – Break up of Revenue by Business Segment (%), 2012
List of Tables:
Table 4-1: Global – In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013
Table 4-2: Global – In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2018
Table 5-1: Europe – Percentage of People Aged 65+ Years in Top-5 IVD Markets (2013 & 2018)
Table 7-1: Abbott Laboratories – Key Financials (Million US$), 2011-2013
Table 7-2: Abbott Laboratories – Strengths and Weaknesses
Table 7-3: Alere Inc. – Key Financials (Million US$), 2010-2012
Table 7-4: Alere Inc. – Strengths and Weaknesses
Table 7-5: Becton Dickinson – Key Financials (Million US$), 2011-2013
Table 7-6: Becton Dickinson – Strengths and Weaknesses
Table 7-7: Bayer HealthCare – Key Financials (Million €), 2011-2013
Table 7-8: Bayer HealthCare – Strengths and Weaknesses
Table 7-9: Beckman Coulter – Strengths and Weaknesses
Table 7-10: Biomerieux – Key Financials (Million €), 2011-2013
Table 7-11: Biomerieux – Strengths and Weaknesses
Table 7-12: Johnson & Johnson – Key Financials (Million US$), 2011-2013
Table 7-13: Johnson & Johnson – Strengths and Weaknesses
Table 7-14: Life Technologies Corporation – Key Financials (Million US$), 2010-2012
Table 7-15; Life Technologies Corporation – Strengths and Weaknesses
Table 7-16: Medtronic Inc. – Key Financials (Million US$), 2011-2013
Table 7-17; Medtronic Inc. – Strengths and Weaknesses
Table 7-18: Qiagen NV – Key Financials (Million US$), 2011-2013
Table 7-19: Qiagen NV – Strengths and Weaknesses
Table 7-20: Roche Holding Ltd – Key Financials (Million CHF), 2011-2013
Table 7-21; Roche Holding Ltd – Strengths and Weaknesses
Table 7-22: Sysmex Corp. – Key Financials (Million Yen), 2011-2013
Table 7-23: Sysmex Corp. – Strengths and Weaknesses
Table 7-24: Siemens AG – Key Financials (Million €), 2011-2013
Table 7-25: Siemens – Strength and Weaknesses
Table 7-26: Thermo Fisher Scientific – Key Financials (Million US$) 2010-2012
Table 7-27: Thermo Fisher Scientific Inc. – Strengths and Weaknesses
【レポート販売概要】
■ タイトル：世界の体外診断市場動向2018■ 英文：In-Vitro Diagnostics Market Outlook 2018
■ 発行日：2014年4月
■ 調査会社：RNCOS
■ 商品コード：RNCOS4041303
■ 調査対象地域：グローバル
- Calvalley Petroleum Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Calvalley Petroleum Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Calvalley Petroleum Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 超音波センサの世界市場2016-2020About Ultrasonic sensors Ultrasonic sensors are transceivers that send and receive ultrasonic waves. They interpret the time taken by an echo to reflect back from an object using the speed of sound as the parameter. These sensors are quite immune to environmental influence, have the ability to detect almost any material, and are not affected by problematic surfaces. They can also meet diverse appl …
- 創傷ケア製品の世界市場：先進創傷ケア（フォームドレッシング、アルギン酸、NPWT、アクティブ）、手術式創傷ケア、従来式創傷ケアThe global wound care market involves various products that help in healing and preventing infection. This market is driven by several factors which include the rising incidences of hospital-acquired infections and the increasing awareness about the latest technologies in the market. Government initiatives in the forms of grants and funds and technological advancements due to which new and innovat …
- ナノロボティクスの世界市場予測（～2023年）Increasing government support and level of investment in nanorobotics, growing advancements in molecular robots, and rising focus on nanotechnology and regenerative medicine acts as major driving factors for nanorobotics marketThe nanorobotics market is expected to reach USD 8.3 billion by 2023 from USD 4.9 billion in 2018, at a CAGR of 11.1%. This growth can be attributed to the increasing govern …
- 企業向けアプリケーション市場：技術及び市場動向Summary Enterprise applications continue to form the backbone of most organizations' enterprise infrastructure. Enterprise applications have come a long way, from being an on-premise standalone solution to becoming mobility and cloud computing enabled enterprise applications that are often closely integrated with other business applications. Furthermore, global customers and the need for widesprea …
- Gliosarcoma：グローバル臨床試験レビューH2, 2013Gliosarcoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gliosarcoma Global Clinical Trials Review, H2, 2013" provides data on the Gliosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gliosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of …
- リスク分析の世界市場：ソリューション（ETLツール、リスク計算エンジン）、サービス、アプリケーションThe risk analytics solutions are widely being adopted by businesses across a broad spectrum of verticals, such as Banking and Financial services, Insurance, manufacturing, logistics & transportation, retail & consumer goods, telecommunication & IT, media & entertainment, government, healthcare, energy & utilities, and others. With the rising acknowledgements to risk analytics, this software applic …
- 世界のセルロースエーテル市場2015The Global Cellulose Ethers Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Cellulose Ethers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Cellulose Ethers market analysis is provided for the international markets including development trends, …
- 世界のSoy Products市場におけるM&A動向（2014年2月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global soy products market during February 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global soy products market throughout the month. Additionally, the report provides an overview of all t …
- 副腎皮質癌治療薬の世界市場：化学療法、標的療法Global Adrenocortical Carcinoma Drugs Market: About this market Adrenocortical carcinoma drugs significantly include chemotherapeutics. Technavio’s adrenocortical carcinoma drugs market analysis considers sales from chemotherapy and targeted therapy segments. Our analysis also considers the sales of adrenocortical carcinoma drugs Asia, Europe, North America, and ROW. In 2018, the chemotherapy segm …
- Chlamydia：医療検査市場2014The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- ギ酸の世界市場2015-2019About Formic Acid Market Formic acid is a carboxylic acid that is used as a chemical intermediate in various end-use applications. It is a colourless liquid formed by the reaction of sulphuric acid with sodium formate. Formic acid is commercially available in concentrations of 78%, 80%, 85%, 94% and 99%, of which the one with 85% concentration is the most widely sought. The acid is also produced a …
- 中国のIoT（モノのインターネット）市場2016-2020About the IoT Market in China The IoT technology helps connect any device to the internet. Devices such as smartphones, household appliances, and wearable devices can be part of the IoT ecosystem and can be controlled through the internet. The IoT works as the core of modern concepts such as smart homes, smart shopping, smart transportation, and smart healthcare. The IoT has started to scale and d …
- オーラルケアの世界市場分析：歯ブラシ、歯みがき、マウスウォッシュ、リンス、総義歯、デンタル付属品The global oral care market is anticipated to reach USD 40.92 billion by 2025, according to a new report by Grand View Research, Inc. Growing awareness among people regarding oral hygiene and increasing incidence of dental caries has led to high growth of the market. Awareness about dental hygiene is increasing among people of both developed as well as developing regions. Various awareness program …
- 自動車用コックピットモジュールの世界市場2019-2023About this market In-car personalization experience enhances customer satisfaction without compromising on vehicle safety and quality. A vehicle owner makes purchasing choices that reflect one's character and style statement. Regulatory norms prohibit any major modification in vehicle structure, but an all-featured center console on the fingertips enhances the premium appeal of a cabin's ergonomic …
